Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 948,322 shares of BHC stock, worth $5.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

948,322

Previous 948,322 -0.0%

Holding current value

$5.86 Million

Previous $6.14 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$6.16 - $7.94 $2.88 Million - $3.71 Million	467,270 Added 97.14%	948,322 $6.14 Million
Q4 2024 Feb 11, 2025	SELL	$7.34 - $9.78 $21.7 Million - $29 Million	-2,962,446 Reduced 86.03%	481,052 $3.88 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $10.1 Million - $16 Million	-1,941,538 Reduced 36.05%	3,443,498 $28.1 Million
Q2 2024 Aug 13, 2024	BUY	$6.1 - $10.41 $20.7 Million - $35.4 Million	3,398,277 Added 171.05%	5,385,036 $37.5 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $4.05 Million - $5.53 Million	521,198 Added 35.56%	1,986,759 $21.1 Million
Q4 2023 Feb 13, 2024	BUY	$6.53 - $8.23 $863,507 - $1.09 Million	132,237 Added 9.92%	1,465,561 $11.8 Million
Q3 2023 May 14, 2024	SELL	$7.69 - $9.71 $1.02 Million - $1.28 Million	-132,237 Reduced 9.02%	1,333,324 $11 Million
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $3.25 Million - $4.11 Million	-422,890 Reduced 24.08%	1,333,324 $11 Million
Q2 2023 May 14, 2024	BUY	$5.72 - $8.8 $1.6 Million - $2.46 Million	279,204 Added 18.9%	1,756,214 $14 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $1.6 Million - $2.46 Million	279,204 Added 18.9%	1,756,214 $14 Million
Q1 2023 May 14, 2024	SELL	$6.28 - $9.85 $53.7 Million - $84.2 Million	-8,543,903 Reduced 85.26%	1,477,010 $12 Million
Q1 2023 May 11, 2023	SELL	$6.28 - $9.85 $53.7 Million - $84.2 Million	-8,543,903 Reduced 85.26%	1,477,010 $12 Million
Q4 2022 May 14, 2024	BUY	$6.09 - $7.93 $46.1 Million - $60.1 Million	7,577,847 Added 310.18%	10,020,913 $62.9 Million
Q4 2022 Feb 13, 2023	BUY	$6.09 - $7.93 $46.1 Million - $60.1 Million	7,577,847 Added 310.18%	10,020,913 $62.9 Million
Q3 2022 May 14, 2024	BUY	$4.58 - $9.21 $2.45 Million - $4.93 Million	535,082 Added 28.04%	2,443,066 $16.8 Million
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $2.45 Million - $4.93 Million	535,082 Added 28.04%	2,443,066 $16.8 Million
Q2 2022 May 14, 2024	BUY	$7.06 - $23.63 $3.12 Million - $10.5 Million	442,423 Added 30.19%	1,907,984 $16 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $9.18 Million - $30.7 Million	1,300,031 Added 213.84%	1,907,984 $16 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $4.96 Million - $6.39 Million	-229,784 Reduced 27.43%	607,953 $13.9 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $168,268 - $212,237	7,316 Added 0.88%	837,737 $23.1 Million
Q3 2021 Nov 10, 2021	BUY	$25.04 - $30.06 $20.8 Million - $25 Million	830,421 New	830,421 $23.1 Million

Others Institutions Holding BHC

# of Institutions

271

Shares Held

243M

Call Options Held

3.66M

Put Options Held

11.3M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.24B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History